top of page

Technology

Hera Health Solutions is a biotechnology company revolutionizing how medicines are delivered through our proprietary nanotechnology-enabled drug delivery platform. Our platform harnesses biodegradable nanofiber scaffolds engineered to control how therapies are released into the body—delivering medicines steadily over days, months, or even years. By reformulating existing therapeutics into long-acting implants, patches, and other delivery formats, we enable pharmaceutical companies to dramatically improve treatment efficacy, reduce side effects, and enhance patient convenience.

Compatible Across Molecules & APIs

Hera’s nanofiber platform has demonstrated the capacity to deliver both small molecules and large biologics, supported by preclinical testing and long-acting drug delivery data. The architecture and fine-tuning of parametric manufacturing controls enable tunable release profiles that can be adapted to match different therapeutic needs. The same framework can also be designed to incorporate and release multiple APIs within a single system, creating opportunities for combination therapies and advanced treatment strategies for therapeutic reformulations. 

multiple_API_edited.jpg

Fine-Tunable Delivery 

Our platform overcomes the limitations of oral dosing and current long-acting injectables and implants by enabling customizable, finely tuned drug release profiles. Instead of fluctuating levels or uncontrollable burst effects, our biodegradable nanofiber scaffolds are engineered to match the therapeutic's release window precisely—delivering medication steadily, safely, and for the exact duration needed.

Screenshot 2025-09-19 at 11.49.33 PM.png

Benefits

Partnerships

Trusted by global pharmaceutical companies and governmental agencies, we are focused on creating therapeutic formulations that address some of the most pressing healthcare and industry challenges. Partner with us to match our platform with your existing APIs and develop more effective, sustainable therapeutics that improve patient outcomes and expand market opportunities.

bottom of page